Today: 17 May 2026
Browse Category

NYSE:INFQ 23 February 2026 - 17 May 2026

Infleqtion (INFQ) stock sinks in early trade as tariff jitters bite — what to watch next

Infleqtion (INFQ) stock sinks in early trade as tariff jitters bite — what to watch next

Infleqtion shares dropped about 10% to $11.95 Monday morning, falling below their opening price amid broader market declines tied to new U.S. tariff uncertainty. The quantum technology firm, which debuted last week after merging with Churchill Capital Corp X, saw about 686,000 shares traded by mid-morning. Investors await the company’s March 11 Analyst Day for more detailed guidance.
23 February 2026
·

Stock Market Today

  • Top NASDAQ Stocks Under $5 to Watch Amid AI Revolution
    May 16, 2026, 9:36 PM EDT. The article highlights the surge in generative AI technology, described by Amazon CEO Andy Jassy as a "once-in-a-lifetime" innovation. Elon Musk foresees a $250 trillion AI market by 2040, eclipsing major tech firms' valuations. Industry giants like Bill Gates, Larry Ellison, and Warren Buffett acknowledge AI's transformative potential. The focus shifts from household names like Nvidia and Microsoft to a lesser-known company advancing AI technology, positioned for significant growth. Investors are urged to explore opportunities in this emerging player, pivotal in the AI ecosystem reshaping the global economy.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Go toTop